[ARS] Aptevo Therapeutics Inc SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

07/03/2025 - 04:15 PM

ARS - Aptevo Therapeutics Inc

ARS Filing - Aptevo Therapeutics Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Aptevo Therapeutics Inc (APVO)

Acceptance Date: 2025-07-03T16:15:12.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

#10549 Ranked by Market Cap

N/A Ranked by Dividends

APVO Latest News

Jun 20, 2025

Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules

Jun 20, 2025

Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers

Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules

Jun 18, 2025

Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML

Jun 13, 2025

Aptevo Participating in the BIO International Convention

APVO Latest SEC Filings

Jul 1, 2025

[8-K] Aptevo Therapeutics Inc Reports Material Event

Jun 30, 2025

[8-K] Aptevo Therapeutics Inc Reports Material Event

Jun 25, 2025

[SCHEDULE 13G] Aptevo Therapeutics Inc SEC Filing

Jun 25, 2025

[SCHEDULE 13G] Aptevo Therapeutics Inc SEC Filing

Jun 23, 2025

[PRE 14A] Aptevo Therapeutics Inc Preliminary Proxy Statement

APVO Stock Data

Market Cap 9.25M

Float 2.58M

Insiders Ownership 0.01%

Institutions Ownership 4.85%

Short Percent 4.12%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City SEATTLE